We were engaged by a national network of oncology practices that was forming a new data commercialization company. In connection with the formation of the new data commercialization company, our client planned to license its existing/future clinical oncology and clinico-genomic data generated by its affiliated oncology practices.

Our team assisted with determining the FMV licensing fees payable for use of this subject data on both an exclusive and non-exclusive basis.